These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38976567)

  • 1. Serum and Urine Metabolic Fingerprints Characterize Renal Cell Carcinoma for Classification, Early Diagnosis, and Prognosis.
    Xu X; Fang Y; Wang Q; Zhai S; Liu W; Liu W; Wang R; Deng Q; Zhang J; Gu J; Huang Y; Liang D; Yang S; Chen Y; Zhang J; Xue W; Zheng J; Wang Y; Qian K; Zhai W
    Adv Sci (Weinh); 2024 Sep; 11(34):e2401919. PubMed ID: 38976567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
    Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons.
    Xu G; Xiang CQ; Lu Y; Wang WJ; Kang XN; Liao P; Ding Q; Zhang YF
    Technol Cancer Res Treat; 2009 Jun; 8(3):225-30. PubMed ID: 19445540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
    Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
    JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
    Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
    Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Protein Profiling in a Cohort of Egyptian Population with Renal Cell Carcinoma and Benign Kidney Neoplasms.
    Kandil NS; Ghazala RA; El Sharkawy RM; Youssif TA; Noha Abouseda N
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2145-2152. PubMed ID: 31350978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
    Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
    Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and urine analysis with gold nanoparticle-assisted laser desorption/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery.
    Arendowski A; Ossoliński K; Ossolińska A; Ossoliński T; Nizioł J; Ruman T
    Adv Med Sci; 2021 Sep; 66(2):326-335. PubMed ID: 34273747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern.
    Wu DL; Zhang WH; Wang WJ; Jing SB; Xu YM
    Technol Cancer Res Treat; 2008 Jun; 7(3):155-60. PubMed ID: 18473487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteomic analysis in combination with CT diagnosis to distinguish renal cell carcinoma from renal benign masses].
    Xu G; Xiang CQ; Lu Y; Kang XN; Wang WJ; Liao P; Ding Q; Zhang YF
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):858-60. PubMed ID: 18756995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry.
    Hara T; Honda K; Ono M; Naito K; Hirohashi S; Yamada T
    J Urol; 2005 Oct; 174(4 Pt 1):1213-7. PubMed ID: 16145372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor size, stage and grade alterations of urinary peptidome in RCC.
    Chinello C; Cazzaniga M; De Sio G; Smith AJ; Grasso A; Rocco B; Signorini S; Grasso M; Bosari S; Zoppis I; Mauri G; Magni F
    J Transl Med; 2015 Oct; 13():332. PubMed ID: 26482227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
    Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
    Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
    Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
    BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot investigation of a urinary metabolic biomarker discovery in renal cell carcinoma.
    Zhang M; Liu X; Liu X; Li H; Sun W; Zhang Y
    Int Urol Nephrol; 2020 Mar; 52(3):437-446. PubMed ID: 31732842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).
    Alves G; Pereira DA; Sandim V; Ornellas AA; Escher N; Melle C; von Eggeling F
    Int Braz J Urol; 2013; 39(2):228-39. PubMed ID: 23683669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
    Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
    Dis Markers; 2014; 2014():135649. PubMed ID: 24803718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.